Today’s outage/interruption of service is a great reminder for us in the clinical trials industry about the importance of business continuity and testing business continuity plans. As an industry, we rely quite heavily on cloud-based technology that is managed by large technology companies such as Microsoft and accept the redundancy, replication, and security infrastructure they provide. We also accept that these companies refuse to be audited by individual companies and provide us with a series of reports demonstrating their risk management practices. Clearly, today’s incident shows that large companies are not perfect and subject to outages and vendor management issues which lead to disruption. Given that, we need to remain vigilant about business continuity and ensure our technology solutions that support our clinical trials can withstand disruption like observed today with no impact on patient safety and minimal experience for clinical trial patients. #businesscontinuity #biotechnology
Harbor Clinical
Biotechnology Research
Hingham, Massachusetts 8,231 followers
Committed to Quality. Committed to You.
About us
Harbor Clinical is a niche CRO with headquarters in the Boston biotech area. Offering both traditional CRO outsourcing models as well as Functional Service Provider (FSP) relationships in clinical research, Harbor Clinical's mission is based on the goal of forging innovative partnerships, with sponsors and employees, built on a bedrock of communication and transparency. Our collaboration with our clients is ongoing, allowing us to provide the right solution at the right time that is flexible and scalable. Quality Assurance is a core competency and service offering. Given that, quality is embedded in everything we do. Our experienced professionals are aligned therapeutically and operationally with your needs and work either remotely or in your office, depending on your company’s culture and requirements. Our core competencies include: • Quality Assurance (Inspection Readiness, site/vendor audits, etc) • Vendor Oversight • Clinical Operations with multiple eTMF solutions available • Data Management with multiple EDC solutions available • Programming • Biostatistics • Medical Management • Pharmacovigilance with safety database available • Medical Writing
- Website
-
https://www.harborclinical.com/
External link for Harbor Clinical
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Hingham, Massachusetts
- Type
- Partnership
- Founded
- 2017
- Specialties
- Clinical Operations, Clinical Quality Assurance, GCP, Medical Writing, Safety Management, Data Management, Regulatory Affairs, CRO Oversight, Biostatistics, FSP, Vendor Oversight, Vendor Management, Site Audits, Vendor Audits, Quality Assurance, Inspection Readiness, Functional Service Provider, Clinical Resourcing, and Staff Augmentation
Locations
-
Primary
Otis St
Hingham, Massachusetts 02043, US
Employees at Harbor Clinical
Updates
-
Women-Owned Wednesday! Today we’re recognizing the work of Paula T. Hammond, a renowned chemical engineer and the Vice Provost for Faculty at the Massachusetts Institute of Technology (MIT). Dr. Hammond’s lab designs polymers and nanoparticles for drug delivery and energy-related product applications. Dr. Hammond has received numerous awards during her career. She’s a member of the National Academy of Medicine and the National Academy of Engineering and served on the President’s Council of Advisors on Science and Technology under Joe Biden. Source: https://hubs.li/Q02Czg_V0 #womenownedwednesday #WOW #chemicalengineering #MIT #polymers #nanoparticles #drugdelivery #nationalacademyofmedicine #nationalacademyofengineering #STEM
-
-
Downsizing is traumatic for your organization and team members, but communicating layoffs with empathy can make all the difference. This article from Harvard Business Review highlights 6 of the most common mistakes leaders make when announcing layoffs. As author Amii Barnard-Bahn eloquently states, familiarizing yourself with these pitfalls can “help you treat your team members with compassion, dignity, and respect when it’s needed most.” Source: https://hubs.li/Q02Cz9cx0 #leadershiptips #executivesuite #communications #professionaldevelopment #communicatinglayoffs #layoffs #harvardbusinessreview #difficultconversations
-
-
A developmental risk management profile (DRMP) is key to your success as a pharmacovigilance specialist. Without this essential document, there’s no way to identify, characterize, or manage risks associated with the drug or therapeutic in development. DRMPs aren’t required by law, but they can be invaluable in preventing headaches, especially for small clinical-stage companies. This Clinical Leader guest column covers everything you need to know: Source: https://hubs.li/Q02Cz9cv0 #developmentalriskmanagementprofile #DRMP #pharmacovigilance #drugdevelopment #clinicaldevelopmentplans #riskminimzationstrategies #riskidentification #riskcharacterization
-
-
Need more evidence that artificial intelligence is here to stay? Look no further than Clario’s recent acquisition of AI startup ArtiQ. As part of the deal, ArtiQ CEO and co-founder Marko Topalovic will continue running his company in addition to leading Clario’s overall AI strategy. ArtiQ develops AI solutions for diagnosing and treating patients with respiratory diseases. Both organizations hope their partnership leads to advances in treatments and therapeutics in the respiratory space. Source: https://hubs.li/Q02Czf9G0 #clario #artificialintelligence #respiratorydiseases #contractresearchorganizations #CRO #artiQ
-
-
Women-Owned Wednesday! This post pays tribute to Alma Levant Hayden, an American chemist and one of the first African American women to gain a scientist position at a scientific agency in Washington D.C. Hayden served at various agencies during her illustrious career, including the Food and Drug Administration (FDA) and the National Institutes of Health (NIH). Her research was instrumental in identifying the ingredients in Krebiozen, a controversial and expensive alternative cancer treatment. Although Hayden passed away in 1967, her legacy lives on to this day. Source: https://hubs.li/Q02Czh7f0 #womenownedwednesday #WOW #FDA #NIH #womeninscience #STEM #womeninSTEM #krebiozen #cancerresearch #almalevanthayden
-
-
The first day of CTO 2024 is off to a great start! Swing by and see Chris Conner and Ann Conner at booth 29. #CTOEastcoast #ClinicalTrials #Oncology #healthcare #pharma
-
-
More than 500,000 American men undergo vasectomies each year. The procedure has remained basically the same for the last 40 years, but that could change soon, thanks to a new medical device developed by Signati. Called the Separo, the device cuts and seals each part of the vas deferens (the tubes that carry sperm) in just 4 seconds. The tool aims to reduce procedure time and offer a minimally invasive treatment approach. Currently, Signati is enrolling patients in a clinical trial. Source: https://hubs.li/Q02Czb3q0 #clinicaltrials #medicaldevices #signati #separo #vasectomies #menshealth #urology #signatimedical #minimallyinvasivesurgery
-
-
Our team is gearing up for Clinical Trials in Oncology East Coast 2024! We hope to see you there, please find us at booth 29. #CTOEastcoast #ClinicalTrials #Oncology #healthcare #pharma
-
-
Clarkson Consulting recently released the results of its third annual CIO survey and it provides invaluable insights into the current relationship between IT and other departments, the enterprise resources companies are investing in, and the most valuable attributes when selecting outsourcing or managed services partners. Click the provided link to learn more, but here’s a spoiler: In 2024 budgeting is more important than ever and AI is on the rise. Source: https://hubs.li/Q02Cz4Hl0 #CIO #lifesciencescompanies #budgeting #AI #clarksonconsulting #cheifinformationofficer #strategicplanning #organizationalresiliance #ITbudgetallocation #ethicalAIusage
-